These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 25454799

  • 1. Consortium on the Genetics of Schizophrenia (COGS) assessment of endophenotypes for schizophrenia: an introduction to this Special Issue of Schizophrenia Research.
    Swerdlow NR, Gur RE, Braff DL.
    Schizophr Res; 2015 Apr; 163(1-3):9-16. PubMed ID: 25454799
    [Abstract] [Full Text] [Related]

  • 2. The importance of endophenotypes in schizophrenia research.
    Braff DL.
    Schizophr Res; 2015 Apr; 163(1-3):1-8. PubMed ID: 25795083
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study.
    Light G, Greenwood TA, Swerdlow NR, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL.
    Schizophr Bull; 2014 Nov; 40(6):1404-11. PubMed ID: 24903414
    [Abstract] [Full Text] [Related]

  • 4. California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS).
    Stone WS, Mesholam-Gately RI, Braff DL, Calkins ME, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Siever LJ, Silverman JM, Sprock J, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Seidman LJ.
    Schizophr Res; 2015 Apr; 163(1-3):32-7. PubMed ID: 25497440
    [Abstract] [Full Text] [Related]

  • 5. Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenia (COGS-1).
    Seidman LJ, Hellemann G, Nuechterlein KH, Greenwood TA, Braff DL, Cadenhead KS, Calkins ME, Freedman R, Gur RE, Gur RC, Lazzeroni LC, Light GA, Olincy A, Radant AD, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar C, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Green MF.
    Schizophr Res; 2015 Apr; 163(1-3):73-9. PubMed ID: 25682549
    [Abstract] [Full Text] [Related]

  • 6. Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies.
    Radant AD, Millard SP, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Meichle SP, Nuechterlein KH, Olincy A, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Sugar CA, Tsuang MT, Turetsky BI, Tsuang DW.
    Schizophr Res; 2015 Apr; 163(1-3):47-52. PubMed ID: 25553977
    [Abstract] [Full Text] [Related]

  • 7. Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study.
    Greenwood TA, Lazzeroni LC, Maihofer AX, Swerdlow NR, Calkins ME, Freedman R, Green MF, Light GA, Nievergelt CM, Nuechterlein KH, Radant AD, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Gur RC, Gur RE, Braff DL.
    JAMA Psychiatry; 2019 Dec 01; 76(12):1274-1284. PubMed ID: 31596458
    [Abstract] [Full Text] [Related]

  • 8. Neurocognitive performance in family-based and case-control studies of schizophrenia.
    Gur RC, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Gur RE.
    Schizophr Res; 2015 Apr 01; 163(1-3):17-23. PubMed ID: 25432636
    [Abstract] [Full Text] [Related]

  • 9. Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study.
    Greenwood TA, Lazzeroni LC, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL.
    Schizophr Res; 2016 Jan 01; 170(1):30-40. PubMed ID: 26597662
    [Abstract] [Full Text] [Related]

  • 10. The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration.
    Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL.
    Schizophr Bull; 2007 Jan 01; 33(1):33-48. PubMed ID: 17035358
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study.
    Millard SP, Shofer J, Braff D, Calkins M, Cadenhead K, Freedman R, Green MF, Greenwood TA, Gur R, Gur R, Lazzeroni LC, Light GA, Olincy A, Nuechterlein K, Seidman L, Siever L, Silverman J, Stone WS, Sprock J, Sugar CA, Swerdlow NR, Tsuang M, Turetsky B, Radant A, Tsuang DW.
    Schizophr Res; 2016 Jul 01; 174(1-3):1-9. PubMed ID: 27132484
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension.
    Swerdlow NR, Light GA, Thomas ML, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL.
    Schizophr Res; 2018 Aug 01; 198():6-15. PubMed ID: 28549722
    [Abstract] [Full Text] [Related]

  • 15. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.
    Light GA, Swerdlow NR, Thomas ML, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Pela M, Radant AD, Seidman LJ, Sharp RF, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Braff DL, Turetsky BI.
    Schizophr Res; 2015 Apr 01; 163(1-3):63-72. PubMed ID: 25449710
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS.
    Swerdlow NR, Light GA, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Ray A, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL.
    Schizophr Res; 2014 Feb 01; 152(2-3):503-12. PubMed ID: 24405980
    [Abstract] [Full Text] [Related]

  • 18. Is there an association between advanced paternal age and endophenotype deficit levels in schizophrenia?
    Tsuang D, Esterberg M, Braff D, Calkins M, Cadenhead K, Dobie D, Freedman R, Green MF, Greenwood T, Gur R, Gur R, Horan W, Lazzeroni LC, Light GA, Millard SP, Olincy A, Nuechterlein K, Seidman L, Siever L, Silverman J, Stone W, Sprock J, Sugar C, Swerdlow N, Tsuang M, Turetsky B, Radant A.
    PLoS One; 2014 Feb 01; 9(2):e88379. PubMed ID: 24523888
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2.
    Turetsky BI, Dress EM, Braff DL, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Light G.
    Schizophr Res; 2015 Apr 01; 163(1-3):53-62. PubMed ID: 25306203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.